Study to Evaluate the Long-Term Safety, Tolerability, and Biological Activity of ATYR1940 in Patients With Limb Girdle and Facioscapulohumeral Muscular Dystrophy

Conditions:   Facioscapulohumeral Muscular Dystrophy;   Limb Girdle Muscular Dystrophy
Intervention:   Drug: ATYR1940
Sponsor:   aTyr Pharma, Inc.
Enrolling by invitation - verified December 2016
News Type: